TrialCancer medicine2022

A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.

Marcus S Noel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.